Biolife solutions announces the sale of its evo cold chain logistics subsidiary

Bothell, wash. , oct. 7, 2025 /prnewswire/ -- biolife solutions , inc. (nasdaq: blfs) ("biolife" or the "company"), a leading developer and supplier of cell processing tools for the cell and gene therapy ("cgt") market, announces the sale of savsu cleo technologies, llc.

BLFS Ratings Summary

BLFS Quant Ranking